Agilent Technologies, a global leader in life science, diagnostics, and analytical laboratory technologies, has built its reputation on innovation, expertise in engineering, knowledge and collaboration to bring unmatched, robust scientific solutions to the market. With the acquisition of Dako and its comprehensive antibodies portfolio and knowledge in the standardization of antibodies for clinical use, Agilent Technologies will continue to raise the standards within diagnostics.
Built on more than 50 years of experience, our business of antibodies & assay solutions has established lasting partnerships worldwide with partnering companies, ranging from large multinationals to smaller manufacturers and commercial laboratories specializing in the fields of in vitro diagnostics, biotechnology and pharmaceuticals.
We are represented by a global sales force that offers excellent customer service standards to our partners. Projects are coordinated by experienced key account management teams thus providing smooth planning and timely completion. We are dedicated to providing scientific advancement, certainty and building lasting partnerships with our customers.